Infectious disease outbreaks, such as measles, HIV, and mpox, expose critical vulnerabilities across public health systems.

Adults aged 18 to 64 years with high-risk conditions demonstrate higher rates of RSV-related LRTD than those without these conditions.

A study of insured US patients shows that oseltamivir is the primary influenza antiviral, while inpatient use of peramivir continues to grow.

The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Live attenuated measles-mumps-rubella and varicella vaccines are not associated with an increased risk for multiple sclerosis disease relapse.

Implementation of a rapid molecular pneumonia panel is associated with earlier antimicrobial optimization among critically ill patients with pneumonia.

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

For patients with axial spondyloarthritis, bimekizumab, a dual interleukin (IL)-17A and IL-17F inhibitor, is well tolerated over 3 years.

Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.

Studies suggesting a link between COVID-19 vaccination and improved outcomes with ICIs may be driven by pandemic-era confounding and selection bias.

A 24-week treatment with bofanglutide for patients with type 2 diabetes showed meaningful glycemic control, weight loss, and improvements in cardiometabolic risk factors — reductions which seemed at ...

Many young adults lack a primary care provider and utilize urgent care clinics for nonemergency issues instead of scheduling routine checkups.